(19)
(11) EP 2 363 142 B8

(12) CORRECTED EUROPEAN PATENT SPECIFICATION
Note: Bibliography reflects the latest situation

(15) Correction information:
Corrected version no 1 (W1 B1)

(48) Corrigendum issued on:
10.06.2015 Bulletin 2015/24

(45) Mention of the grant of the patent:
25.03.2015 Bulletin 2015/13

(21) Application number: 10180533.1

(22) Date of filing: 24.09.2000
(51) International Patent Classification (IPC): 
A61K 38/48(2006.01)
A61K 31/00(2006.01)
A61K 38/55(2006.01)
A61K 31/167(2006.01)

(54)

Elastase for opening obstructed biological conduits

Elastase zum Öffnen verstopfter biologischer Kanäle

Élastase pour ouvrir des conduits biologiques obturés


(84) Designated Contracting States:
AT BE CH CY DE DK ES FI FR GB GR IE IT LI LU MC NL PT SE

(30) Priority: 24.09.1999 US 155938 P

(43) Date of publication of application:
07.09.2011 Bulletin 2011/36

(62) Application number of the earlier application in accordance with Art. 76 EPC:
07008805.9 / 1923068
00965396.5 / 1220830

(73) Proprietor: Proteon Therapeutics, Inc.
Waltham, MA 02451 (US)

(72) Inventor:
  • Franano, Nicholas F.
    Laurel, MD 20723 (US)

(74) Representative: Adam, Holger 
Kraus & Weisert Patentanwälte PartGmbB Thomas-Wimmer-Ring 15
80539 München
80539 München (DE)


(56) References cited: : 
US-A- 5 116 615
US-A- 5 834 449
US-A- 5 318 531
   
  • DATABASE WPI Week 199018 Thomson Scientific, London, GB; AN 1990-137116 XP002652809, & JP 2 086777 A (SANKYO CO LTD) 27 March 1990 (1990-03-27)
  • KERENYI T ET AL: "LOCAL ENZYMATIC TREATMENT OF ATHEROSCLEROTIC PLAQUES", EXPERIMENTAL AND MOLECULAR PATHOLOGY, ACADEMIC PRESS, US, vol. 49, no. 3, 1 January 1988 (1988-01-01), pages 330-338, XP002430756, ISSN: 0014-4800, DOI: 10.1016/0014-4800(88)90005-6
  • AKIMOTO FUMIKAZU: "The effect of pancreatopeptidase E (Elastase) on anastomotic intimal thickness in two types of vascular prosthesis", SURGERY TODAY,, vol. 25, no. 12, 1 January 1995 (1995-01-01), pages 1027-1033, XP009121339, DOI: DOI:10.1007/BF00311687
  • FUJIOKA K; ESATO K; ZEMPO N: "Effect of elastase on primary graft patency after femoralpopliteal arterial bypass for arteriosclerosis obliterans: a randomized, controlled study.", INTERNATIONAL SURGERY 1997 JAN-MAR LNKD- PUBMED:9189814, vol. 82, no. 1, January 1997 (1997-01), pages 94-97, XP9150609, ISSN: 0020-8868
  • OOYAMA TOSHIRO; SAKAMATO HIROSHI: "Elastase in the prevention of arterial ageing and the treatment of atherosclerosis", CIBA FOUNDATION SYMPOSIUM; THE MOLECULAR BIOLOGY AND PATHOLOGY OF ELASTIC TISSUES JOHN WILEY AND SONS LTD., BAFFIN LANE, CHICHESTER PO 19 1UD, ENGLAND; JOHN WILEY AND SONS, INC., 605 THIRD AVENUE, NEW YORK, NEW YORK 10158-0012, USA SERIES : CIBA FOUN, 1995, pages 307-317, XP009150607, SYMPOSIUM; NAIROBI, KENYA; NOVEMBER 1-3, 1994
   
Note: Within nine months from the publication of the mention of the grant of the European patent, any person may give notice to the European Patent Office of opposition to the European patent granted. Notice of opposition shall be filed in a written reasoned statement. It shall not be deemed to have been filed until the opposition fee has been paid. (Art. 99(1) European Patent Convention).